<scp>MUC</scp>1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism
Dina Stroopinsky(Beth Israel Deaconess Medical Center), David Avigan(Beth Israel Deaconess Medical Center)
Cited by 15
Related Papers
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
|Journal of Clinical Oncology|2013|439